GLP-3 Research Peptide | Lab Tested | PrecisionsPeptides.com

Groov Bioscience GLP-3

Colten — Mon, 01 Jun 2026 20:26:14 +0000

Retatrutide is a synthetic peptide research compound acting as a triple agonist at the GIP, GLP-1, and glucagon receptors. Researchers study it to examine three metabolic pathways engaged together.

In cultured cells and laboratory animals, work has focused on glucose regulation, energy output, lipid processing, and integrated three-receptor signaling. Its multi-target profile suits comparative metabolic research.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Groov Bioscience GLP-3 appeared first on PrecisionsPeptides.com.

NuLumin GLP-3

Graham — Fri, 19 Jun 2026 00:37:05 +0000

GLP-3 is NuLumin’s designation for retatrutide, a synthetic peptide research compound acting as a triple agonist at the GIP, GLP-1, and glucagon receptors. In laboratory research it is studied across three metabolic pathways at once.

Preclinical literature describes investigations into glucose regulation, energy output, lipid processing, and integrated three-receptor signaling, carried out using cell-based assays and animal studies. Its three-receptor design suits comparative work across metabolic pathways.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post NuLumin GLP-3 appeared first on PrecisionsPeptides.com.

Catalyst Compounds GLP-3

Colten — Wed, 17 Jun 2026 18:20:41 +0000

Retatrutide is a synthetic peptide research compound characterized as a triple agonist acting at the GIP, GLP-1, and glucagon receptors. It is used to study convergent incretin and glucagon signaling.

Research has examined glucose regulation, energy expenditure, lipid handling, and multi-receptor signaling integration in cell cultures and rodent models. Its triple-receptor activity supports comparative study of combined metabolic pathways.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Catalyst Compounds GLP-3 appeared first on PrecisionsPeptides.com.

Real Peptides GLP-3

Graham — Wed, 17 Jun 2026 22:14:17 +0000

Retatrutide is a synthetic peptide research compound characterized as a triple agonist at the GIP, GLP-1, and glucagon receptors. It has been studied in preclinical research as a tool compound for isolating multi-receptor incretin and glucagon signaling endpoints in metabolic experimental designs.

Retatrutide has been examined in preclinical in vitro and rodent model studies of glucose homeostasis, energy expenditure, lipid metabolism, and triple receptor signaling dynamics. Its combined receptor activity supports comparative mechanistic studies of incretin and glucagon biology in cell-based and rodent research.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.

The post Real Peptides GLP-3 appeared first on PrecisionsPeptides.com.